---
type: "Topics"
locale: "en"
url: "https://longbridge.com/en/topics/39928866.md"
description: "IBM's ability to implement enterprise AI relies on the watsonx platform, with the conversion of To-B AI orders in 2026 being a key KPI; its PE of around 20x is within a reasonable range.Tempus AI focuses on medical AI data analysis, with revenue growth exceeding 40% but still unprofitable; its valuation needs to be measured by the PS ratio, and a PS of around 15x indicates high market expectations.C3 AI recently missed both earnings and revenue estimates and lowered its guidance, with its stock price falling over 20%; it is currently an underperformer, awaiting signals of a fundamental rebound next quarter."
datetime: "2026-04-15T11:02:51.000Z"
locales:
  - [en](https://longbridge.com/en/topics/39928866.md)
  - [zh-CN](https://longbridge.com/zh-CN/topics/39928866.md)
  - [zh-HK](https://longbridge.com/zh-HK/topics/39928866.md)
author: "[ひかりちゃん](https://longbridge.com/en/profiles/26499202.md)"
---

# IBM's ability to implement enterprise AI relies on…


### Related Stocks

- [IBM.US](https://longbridge.com/en/quote/IBM.US.md)
- [TEM.US](https://longbridge.com/en/quote/TEM.US.md)
- [AI.US](https://longbridge.com/en/quote/AI.US.md)

## Comments (1)

- **切克闹凌凌漆 · 2026-04-15T12:43:55.000Z**: Commercial implementation is the real turning point.